Impact of Direct Acting Antiviral Agents on Psychiatric and Sexual Health of Patients with Hepatitis C Virus
Journal Title: Viral Hepatitis Journal - Year 2019, Vol 25, Issue 1
Abstract
Objectives: Data about the psychosocial side effects of directacting antiviral agents (DAA) used for the treatment of hepatitis C virus (HCV) infection is scarce. In this study, it is aimed to assess the psychiatric and sexual effects of ledipasvir/sofosbuvir (L/S) combination and paritaprevir-ritonavir-ombitasvir-dasabuvir (PROD) combination in patients with HCV infection. Materials and Methods: The sample of this retrospective study consisted of patients who were diagnosed with HCV infection and received PROD or L/S treatment. The patients were assessed by the Hospital Anxiety and Depression (HAD) scale and Arizona Sexual Experiences (ASEX) scale at baseline and first-, third- and sixth-month visits. Besides these, demographic data and data about the liver disease were collected. Results: During the studied period, 42 patients were started DAA treatment. The average age of the sample was 56.64±12.04 years. Thirty-five (83.3%) patients achieved sustained viral response. Data of the patients who filled HAD or ASEX at baseline and at least in one of the following visits within six months were used. Anxiety, depression and sexual measures did not differ between baseline and following assessments. Conclusion: L/S and PROD do not seem to have a significant effect on anxiety and depression levels and sexual experiences of the patients while they made an improvement in viral load.
Authors and Affiliations
Özlem Kuman Tunçel, Deniz Akyol, Hüsnü Pullukçu, Tansu Yamazhan, Meltem Işıkgöz Taşbakan, Özen Önen Sertöz
Keywords
Related Articles
- EP ID EP551630
- DOI 10.4274/vhd.galenos.2019.0006
- Views 78
- Downloads 0
The Epidemiology and Trend of Hepatitis C Infection in Hamadan Province: West of Iran, 2011-2016
Amaç: Hepatit C virüsü (HCV), küçük miktarda kanla temas yoluyla bulaşan bir virüstür. Bu çalışmada, 2011-2016 yılları arasında, Hamadan bölgesinde ardışık yedi yıl boyunca hepatit C enfeksiyonunun trendi ve epidemiyoloj...
Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t)ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience
Objective: The aim of the study was to evaluate the long-term results of treatment efficacy and safety in nucleos(t)ide analogue-naive (NA-naive) and NA-experienced chronic hepatitis B (CHB) patients receiving tenofovir...
Hepatitis B Virus Vaccination Rates among Medical Laboratory Workers: A Multi-centered Assessment
Objective: In this multicenter study, we aimed to determine the rates of hepatitis B virus (HBV) in medical laboratory workers in Turkey and to discuss the current status. Materials and Methods: We designed this study as...
Frequency of Hepatitis Delta Virus in Hepatitis B Surfaceantigen-positive Patients
Objectives: The prevalence of hepatitis delta virus (HDV) worldwide shows geographical differences. Although there are several studies on anti-HDV seroprevalence rates in hepatitis B surface antigen (HBsAg)-positive pati...
A Rare Side Effect of Entecavir: Hepatomegaly and Steatosis
Hepatomegaly and steatosis are rare but potentially fatal side-effects of nucleoside analogues. Here, we present the case of development of hepatomegaly and steatosis in a 53-year-old male who had been treated with entec...